Share on Facebook Share on Twitter

Thread Rating:
  • 1 Vote(s) - 5 Average
  • 1
  • 2
  • 3
  • 4
  • 5
Quicker access to Paxlovid
The FDA has issued an Emergency Use Authorization allowing a state-licensed pharmacist to prescribe Paxloviid to patients under certain conditions:
  • The patient must be at high risk of developing severe COVID (CDC ;  NIH)
  • The prescriber must have recent (12-month) blood work that shows no issues with liver or kidneys
  • The patient must have mild to moderate COVID (I don't know that asymptomatic COVID is considered "mild")

A self-reported positive home antigen test is allowed for evidence of COVID.

Previously and still, Paxlovid was available at Test-to-treat sites.
Now, it should be more easily available.

(I recently had to get a (non-COVID) vaccine.  I went to one of the pharmacies a couple of miles away that is also a test-to-treat site.  They were 45 minutes behind their appointments.   Now I should be able to get it at a more local, less backed-up neighborhood pharmacy.)

I find the CDC's info on high risk to be a bit confusing.  It is easy to read it as just being a list of comorbidities.  But 65+ is actually one of the (not-obviously listed) high risks.
Thanks for sharing this, I was just looking to see how easy it would be to get for my wife if she were to contract Covid. I'm commenting for easy reference in the future.

Forum Jump:

Users browsing this thread: